Wilmington, Delaware, United States, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - In 2021, the value of global smart drug delivery systems market size was clocked at US$ 8.7 Bn. The growth rate of smart drug delivery systems market is estimated to be 15.2% CAGR during the forecast period, from 2022 to 2031. The global smart drug delivery systems market is anticipated to reach more than US$ 36 Bn by 2031. Increase in the incidence of chronic diseases and growing patient demand for advanced drug delivery systems is projected to fuel growth of smart drug delivery systems market.
Self-medication solutions are becoming more popular around the world as medical technology companies try to make their products more patient-centric. It is anticipated that a number of important breakthroughs will soon influence and revolutionize the field of advanced drug delivery. The pharmaceutical and healthcare sectors as a whole are affected by poor patient compliance, which is a severe problem. Over the past 25 years, there hasn't been much of a change in noncompliance rates, and in the near future, they are likely to rise even more. As a result, industry participants are developing solutions that will enable medications to reach the proper therapeutic levels without the need for repeated administration.
Get Exclusive PDF Sample Copy of Smart Drug Delivery Systems Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85111
The market for smart drug delivery systems was led by North America in 2021, and this dominance is anticipated to continue throughout the forecast period. Spending on research and development has increased, and the use of new and better equipment has risen, which is likely to drive the regional market. In addition, the market is anticipated to be driven by increase in healthcare spending, prompt availability of cutting-edge technologies, and existence of advanced healthcare system.
Key Findings of Market Report
- The market is expected to be dominated by the category for metabolic disorders based on therapeutic area due to the rising incidence of cardiovascular illnesses and diabetes globally. About 422 million people worldwide have diabetes, most of whom reside in low- and middle-income nations, as reported by the WHO. Both diabetes and cardiovascular disease are predicted to drive sales of smart drug delivery systems market.
- In terms of delivery mode, in 2021, the injectable category commanded a sizeable market share owing to the advantages of injections, which include lower dosage frequency, simplicity in use, improved patient compliance, and less discomfort.
- In 2021, the hospitals category held the biggest market share based on end-user. This is explained by the rise in smart medication delivery system usage in hospitals and the growing number of hospitals.
- Autoinjectors are now being developed to support larger viscosities and concentrations and minimize the frequency of medication delivery. It is anticipated that this will increase adherence to advised medication regimes. As a result, the market is likely to observe increasing demand for autoinjectors due to increasing cases of COVID-19.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=85111
Global Smart Drug Delivery Systems Market: Growth Drivers
- Depending on product, in 2021, the category of connected wearable injectors had the greatest market share and the trend is estimated to continue during the forecast timeline. Growing senior populace, increasing worries over needle stick injuries are expected to drive the segment's expansion. Besides, rise in chronic illnesses, and demand for constant health supervision are expected to add to the segment's growth.
- Due to the rising elderly population and increased prevalence of cardiovascular disorders, Asia Pacific is predicted market is expected to observe rapid growth. The regional market is also anticipated to be driven by booming medical tourism and the development of improved healthcare system.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=85111
Global Smart Drug Delivery Systems Market: Key Players
Some of the key market players are
- H&T Presspart Manufacturing Ltd
- Becton, Dickinson and Company
- Novo Nordisk A/S
- E3D Elcam Drug Delivery Devices
- Amiko Digital Health Limited
- CeQur Corporation
Global Smart Drug Delivery Systems Market: Segmentation
Product
- Connected Inhalers
- Connected Autoinjectors
- Connected Pen Injectors
- Connected Wearable Injectors
- Add-on Sensors
- Others
Drug Delivery Mode
- Injectable
- Inhalation
- Oral
Therapeutic Area
- Metabolic Disorders
- Neurological Disorders
- Respiratory Disorders
- Hormonal Disorders
- Others
End User
- Hospitals
- Clinics
- Home Care
- Ambulatory Care Settings
- Others
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Rapid Test Market: The global rapid test market is anticipated to reach more than US$ 62.34 Bn by 2031 at a CAGR of 8.0% from 2022 to 2031.
Refurbished Medical Imaging Equipment Market: The global refurbished medical imaging equipment market is expected to reach US$ 18.3 Bn by the end of 2031 at a CAGR of 9.1% from 2022 to 2031.
Catheter Stabilization Devices Market: The global catheter stabilization devices market is anticipated to reach US$ 2.6 Bn by the end of 2031 at a CAGR of 6.5% from 2022 to 2031.
Trichoscope Devices Market: The global trichoscope devices market is anticipated to reach US$ 73.4 Mn by the end of 2031 at a CAGR of 7.3 % from 2022 to 2031.
Intraosseous Devices Market: The global intraosseous devices market is anticipated to reach more than US$ 778.9 Mn by the end of 2031 at a CAGR of 5.6% from 2022 to 2031.
Arthroscopic Visualization Instruments Market: The global arthroscopic visualization instrument market is anticipated to reach more than US$ 3.2 Bn by 2031 at a CAGR of 4.1% from 2022 to 2031.
Safety Pen Needles Market: The North America safety pen needles market is anticipated to reach more than US$ 1.17 Bn by the end of 2031 at a CAGR of 6.4% from 2022 to 2031.
Magnetic Resonance Imaging Market: The global magnetic resonance imaging market is anticipated to reach more than US$ 10.6 Bn by the end of 2031 at a CAGR of 4.2% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
